ABCL
Price
$11.32
Change
-$0.25 (-2.16%)
Updated
Aug 21 closing price
Capitalization
3.67B
79 days until earnings call
Intraday BUY SELL Signals
CADL
Price
$13.13
Change
+$0.78 (+6.32%)
Updated
Aug 21 closing price
Capitalization
1B
74 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABCL vs CADL

ABCL vs CADL Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ABCL vs. CADL commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and CADL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 23, 2026
Stock price -- (ABCL: $11.32 vs. CADL: $13.13)
Brand notoriety: ABCL and CADL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 49% vs. CADL: 73%
Market capitalization -- ABCL: $3.67B vs. CADL: $1B
ABCL [@Biotechnology] is valued at $3.67B. CADL’s [@Biotechnology] market capitalization is $1B. The market cap for tickers in the [@Biotechnology] industry ranges from $138.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileCADL’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • CADL’s FA Score: 0 green, 5 red.
According to our system of comparison, both ABCL and CADL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 5 TA indicator(s) are bullish while CADL’s TA Score has 3 bullish TA indicator(s).

  • ABCL’s TA Score: 5 bullish, 5 bearish.
  • CADL’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ABCL is a better buy in the short-term than CADL.

Price Growth

ABCL (@Biotechnology) experienced а -0.53% price change this week, while CADL (@Biotechnology) price change was +12.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +15.94%, and the average quarterly price growth was +3349.70%.

Reported Earning Dates

ABCL is expected to report earnings on Nov 10, 2026.

CADL is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($3.67B) has a higher market cap than CADL($1.01B). ABCL YTD gains are higher at: 230.994 vs. CADL (132.389). CADL has higher annual earnings (EBITDA): -50.3M vs. ABCL (-167.02M). ABCL has more cash in the bank: 505M vs. CADL (195M). CADL has less debt than ABCL: CADL (49.3M) vs ABCL (140M). ABCL has higher revenues than CADL: ABCL (79.2M) vs CADL (0).
ABCLCADLABCL / CADL
Capitalization3.67B1.01B365%
EBITDA-167.02M-50.3M332%
Gain YTD230.994132.389174%
P/E RatioN/AN/A-
Revenue79.2M0-
Total Cash505M195M259%
Total Debt140M49.3M284%
TECHNICAL ANALYSIS
Technical Analysis
ABCLCADL
RSI
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
84%
MACD
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 10 days ago
81%
Bullish Trend 11 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 26 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
Aroon
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signal:
Gain/Loss:
CADL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AEGFX64.950.75
+1.17%
American Funds EUPAC F-1
RLITX14.160.14
+1.00%
Lazard International Strategic Eq R6
TVIRX95.300.80
+0.85%
Thornburg American Opportunities R4
CBEAX11.430.06
+0.53%
Allspring Large Cap Value CL A
AZNAX11.850.03
+0.25%
Virtus Income & Growth A

CADL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CADL has been loosely correlated with RXRX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if CADL jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CADL
1D Price
Change %
CADL100%
+6.32%
RXRX - CADL
45%
Loosely correlated
+4.79%
EDIT - CADL
43%
Loosely correlated
+5.78%
FDMT - CADL
41%
Loosely correlated
-1.68%
CRSP - CADL
40%
Loosely correlated
+2.37%
ABCL - CADL
39%
Loosely correlated
-2.16%
More